Skip to content

Free cash flow at other companies

ResMed logo
ResMedRMD
$520.48M-6.7%
LivaNova logo
LivaNovaLIVN
$926K-93.0%
Stryker logo
StrykerSYK
$415M+227%
ITG
Integer HoldingsITGR
$737K-87.8%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%

Valuation

See full
Market cap$1.24B-68.7%
Enterprise value$1.18B-70.0%
P/E9.5×-50.2×
P/S1.4×-3.4×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Calculated from Inspire Medical Systems’s reported figures.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's free cash flow?
Inspire Medical Systems (INSP) reported free cash flow of $3.12M in Q1 2026.
How has Inspire Medical Systems's free cash flow changed year-over-year?
Inspire Medical Systems's free cash flow increased by 120.7% year-over-year, from -$15.11M to $3.12M.
What is the long-term trend for Inspire Medical Systems's free cash flow?
Over 4 years (2021 to 2025), Inspire Medical Systems's free cash flow has grown at a 33.1% compound annual growth rate (CAGR), from -$24.99M to $78.48M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.